MON-196 Gender-Affirming Hormonal Therapy and Incidence of Metabolic Syndrome and Cardiovascular Events in Patients with Gender Dysphoria

Background: Long-term effects of gender-affirming hormonal therapy (GAHT) on cardiovascular risk factors and metabolic syndrome (MS) is currently unclear. Particularly, the effect of GAHT on cardiovascular outcomes in older individuals (>60 years) with gender dysphoria (GD) is unknown. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mok, Mary, Pinkson, Sheila, Case, Emina, Bruder, Jan, Koops, Maureen, Tripathy, Devjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Reproductive Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550827/
http://dx.doi.org/10.1210/js.2019-MON-196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550827/
http://dx.doi.org/10.1210/js.2019-MON-196

Ejemplares similares